Pfizer Says Expert Testimony In Celebrex Suit Unreliable
Pfizer asked a Virginia federal judge Wednesday to exclude expert testimony supporting the certification of a class of direct purchasers who allege the drugmaker used fraudulent patents to delay generic-drug competition...To view the full article, register now.
Already a subscriber? Click here to view full article